Teva Pharmaceutical Industries Limited
$41.10B- Market cap
- $42.84B
- Debt
- +$1.82B
- Cash
- −$3.56B
Capital structure 96% equity / 4% debt · EV / Revenue 2.38x · EV / EBITDA 10.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
TEVA · price snapshotP/E 30.38x
$36.76Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at INVH's multiple
$35.573.2% below market
1.21 TEVA Annual EPS×29.40x INVH P/E=$35.57
Market $36.76Implied $35.57
INVH · price snapshotP/E 29.40x
$28.22Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at TEVA's multiple
$29.163.3% above market
0.96 INVH Annual EPS×30.38x TEVA P/E=$29.16
Market $28.22Implied $29.16